4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000109
Director sold 20,000 shares at an average $35.61 ($712,110)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2022-07-25 | Sale | −19,800 | $35.60 | $704,880 | 1,950,556 | D |
| Tessier-Lavigne Marc Director | 2022-07-25 | Sale | −200 | $36.15 | $7,230 | 1,950,356 | D |
| Open-market sales · 20,000 sh · avg $35.61 · $712,110 | |||||||
Loading xslF345X03/wf-form4_165896213456047.xml…